Growth Metrics

Sonoma Pharmaceuticals (SNOA) Shares Issued (2017 - 2025)

Sonoma Pharmaceuticals has reported Shares Issued over the past 15 years, most recently at $44000.0 for Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $44000.0; the TTM value through Dec 2025 reached $93000.0, down 65.68%, while the annual FY2025 figure was $82000.0, 95.4% down from the prior year.
  • Shares Issued for Q3 2025 was $44000.0 at Sonoma Pharmaceuticals, down from $49000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $6.9 million in Q3 2021 and troughed at -$7.3 million in Q1 2022.
  • A 5-year average of $521363.6 and a median of $662000.0 in 2021 define the central range for Shares Issued.
  • Biggest five-year swings in Shares Issued: surged 562.55% in 2021 and later plummeted 420.86% in 2022.
  • Year by year, Shares Issued stood at $662000.0 in 2021, then crashed by 1208.46% to -$7.3 million in 2022, then soared by 99.93% to -$5000.0 in 2023, then plummeted by 45020.0% to -$2.3 million in 2024, then skyrocketed by 101.95% to $44000.0 in 2025.
  • Business Quant data shows Shares Issued for SNOA at $44000.0 in Q3 2025, $49000.0 in Q1 2025, and -$2.3 million in Q4 2024.